• Planning Ahead for Transition to the EU’s Medical Device Regulation (MDR): A How-To Guide, Part 1

    19 November, 2018 by Jerry Chapman, GMP Consultant and Editor-in-chief, Xavier Health

    Medical device manufacturers are finding it more difficult than initially anticipated to prepare for the European Union’s (EU) Medical Device Regulation (MDR) transition period, which ends May 2020. Find out what kind of challenges medtech companies are experiencing and how you can create a workable transition plan in this two-part blog series.

    Full story
  • Building an Audit-Ready QMS

    15 November, 2018 by Joy McElroy, Consultant and Business Development Director, Maynard Consulting Company

    Consumers and patients assume manufactured pharmaceuticals are safe and effective. In order for quality units to assure this, you have to have a robust quality control (QC) and quality assurance (QA) program guided by an equally sound quality management system (QMS). Learn the roles of QC and QA and how to create a QMS that will help your company maintain a high level of quality.

    Full story
  • PwC Report Analyzes Health Care Policy Issues

    15 November, 2018 by PricewaterhouseCoopers Health Research Institute

    PwC’s Health Research Institute recently issued a report on the U.S. midterm election that analyzes policy issues that may well impact the American health care industry for years to come, particularly those in the pharmaceutical and life science industries. Learn what this means for manufacturers.

    Full story
  • Quality Assurance and Quality Control: What's the Difference When It Comes to Managing Quality?

    13 November, 2018 by Kimberlee A. Washburn, Regulatory Affairs Author

    Quality assurance and quality control functions in the manufacturing process may share some similarities but they’re actually quite different animals. Learn about the purpose of each and their relationship to each other in enabling life sciences and other regulated manufacturers to maintain a high level of quality and compliance for their products.

    Full story
  • Top 5 Nutraceutical Trends in 2018 - Conducting Clinical Trials on Nutraceuticals

    8 November, 2018 by Sarah Beale, Staff Writer, MasterControl

    Nutraceutical companies have never been required to conduct clinical trials. However, many are now voluntarily taking on this endeavor to show that their products work as advertised. This adds legitimacy to nutraceuticals and provides a better value for consumers, but the complexity of clinical trials presents a significant hurdle.

    Full story
  • Risk Management and the Human Species

    6 November, 2018 by Rai Chowdhary, CEO and Founder, The KPI System

    Science has shown that human beings are not immune from making irrational choices when it comes to risk management, even in the life sciences. This can have significant effect on manufacturing processes, and ultimately, patients. Learn how to avoid falling into this trap.

    Full story
  • Advancing the Regulatory Profession in Utah

    1 November, 2018 by Robert M. Wolfarth, Chairman, RAPS Utah Chapter

    Based on recent economic study and the establishment of the Silicon Slopes technology corridor, Utah has one of the fastest-growing life sciences communities in the U.S. Learn about the Regulatory Affairs Professionals Society’s (RAPS) new Utah Chapter and what the organization is doing to attract more regulatory affairs experts to life sciences careers.

    Full story
  • Top 5 Nutraceutical Trends in 2018 - Getting Creative With Protein

    30 October, 2018 by Sarah Beale, Staff Writer, MasterControl

    The protein supplement category is no longer exclusively for hardcore athletes. The general population is now full of people who are concerned that they’re not getting enough protein in their diets. These consumers are increasingly turning to supplements to fill the void.

    Full story
  • De Novo Becoming Faster and Easier Pathway to Market

    25 October, 2018 by David Jensen, Staff Writer, MasterControl

    There are many pathways to bring a medical device to market. The 510(k) and premarket approval (PMA) are the most common, while the de novo pathway is less popular. Advances in technology and changes in regulatory standards are making the de novo a more attractive option.

    Full story
  • What's Hiding in Your Labeling Artwork?

    23 October, 2018 by Dan Vuksanovich, Regional Sales Manager, Schlafender Hase

    Because there are potential but invisible risks inherent in labeling artwork documents of life science companies that can’t be detected through manual proofreading, it’s important to be thorough and to know the tricks to detect and prevent these snags from causing unnecessary delays in the manufacturing process.

    Full story
  • Advancing the Case for Quality in Medical Device Manufacturing

    18 October, 2018 by Stephanie Christopher, Program Director, Medical Device Innovation Consortium

    We all seek quality in goods and services, but how can that quality be assured? The U.S. Food and Drug Administration’s (FDA) Center for Device and Radiological Health (CDRH), as part of its Case for Quality initiative, last year launched the Voluntary Medical Device Manufacturing Product Quality pilot program based on a maturity model as an alternative to the traditional path of a routine FDA inspection. Find out if the program might be the right step to boost your company’s quality and compliance.

    Full story
  • BraveHeart Team Emphasizes Quality-First Approach

    16 October, 2018 by David Jensen, Staff Writer, MasterControl

    One trap regulated startups should try to avoid is having unrealistic assumptions about what it takes to achieve compliance. Part 3 of this article series features several members of the BraveHeart team discussing their views and expectations for quality throughout the Wearable Life Sensor’s life cycle.

    Full story
  • FMEA Without Tears: A Prescription to Reduce Pain and Confusion

    11 October, 2018 by Rai Chowdhary, CEO and Founder, The KPI System

    Failure modes and effects analysis (FMEA) is a particularly effective tool in risk management. But its use is often accompanied by fear or pain because practitioners struggle to apply it. Learn how to effectively use FMEA without trepidation to improve your company’s risk management operations.

    Full story
  • Airplane Preflight Check Exemplifies Quality in Med Device Design

    10 October, 2018 by David Jensen, Staff Writer, MasterControl

    Before any aircraft leaves the ground, it undergoes a preflight check. Part 2 of this series on BraveHeart features Steve McCalmont performing an aircraft preflight check to illustrate how this critical part of flying equates to the importance of incorporating quality in the design of a medical device.

    Full story
  • Getting Paid: A Shifting Medical Device Reimbursement Landscape in Australia

    9 October, 2018 by Sarah Griffin, Principal Consultant, Brandwood Biomedical (Australia)

    Australia is increasingly an attractive market for medical device manufacturers. But medtech companies need to know the complexities of the country’s blended public and private hospital systems to avoid confusion and fully profit from its device reimbursement opportunities.

    Full story
  • Top 5 Nutraceutical Trends in 2018 - Exploring Different Delivery Methods

    4 October, 2018 by Sarah Beale, Staff Writer, MasterControl

    The nutraceutical world is constantly evolving to meet consumer needs and the search for alternative delivery forms is a prime example of this. To combat pill fatigue, supplements now come in liquids, powders, lotions and sprays, but companies embracing innovation need to be aware of the challenges they face.

    Full story
  • Med Device Company Takes Flight With Life-Changing Innovation

    3 October, 2018 by David Jensen, Staff Writer, MasterControl

    Startup ventures are the embodiment of innovation – often hitting the ground running with little more than an idea and a vision. Part one of this three-part series introduces startup medical device company, BraveHeart Wearable Life Sensors, and how it is uniquely inspired by aviation.

    Full story
  • Expert Tips on Enhancing CAPA Through Innovation

    2 October, 2018 by James Jardine, Staff Writer, MasterControl

    This examination of quality guru Ken Peterson’s proven corrective and preventive action (CAPA) innovation techniques provides strategies and sequential principles for refining transformative CAPA innovations, avoiding half-baked solutions and obtaining organizational buy-in of revolutionary quality event management ideas.

    Full story
  • 10 Key Steps for Implementing a QMS

    27 September, 2018 by Tifany Desprez, Communication & Marketing Manager with MasterControl Partner Apsalys

    Your company needs to an integrated, automated quality management system (QMS) to help you get your products to market faster and more efficiently. Where do you start? Consider these 10 steps to help you audit your current system and processes, get stakeholders onboard, and implement a QMS that will signifcantly improve your company's quality processes.

    Full story
  • How Approaching MDR/IVDR Deadlines Are Impacting Med Device Industry

    26 September, 2018 by David Jensen, Staff Writer, MasterControl

    The countdown to the Medical Device Regulations (MDR) and In Vitro Diagnostics Regulations (IVDR) deadlines is underway. However, transition issues are creating a logistical logjam for both the medical device industry and the European Commission (EC), which is impacting the med device industry. MedTech Europe still wants the EC to stop the clock.

    Full story

 

Browse by Industry

General Manufacturing 8 Medical Device 213 Nutraceuticals 10 Pharma 196 Quality 190